We have located links that may give you full text access.
Continuation of Oral Anti-Diabetic Medications Was Associated With Better Early Post-Operative Blood Glucose Control Compared to Sliding Scale Insulin After Total Knee Arthroplasty.
Journal of Arthroplasty 2024 Februrary 29
BACKGROUND: This study evaluated blood glucose (BG), creatinine levels, metabolic issues, length of stay (LOS), and early post-operative complications in diabetic primary total knee arthroplasty (TKA) patients. It examined those who continued home oral anti-diabetic medications and those who switched to insulin post-operatively. The hypothesis was that continuing home medications would lead to lower BG levels without metabolic abnormalities.
METHODS: Patients diagnosed who had diabetes who underwent primary TKA from 2013 to 2022 were evaluated retrospectively. Diabetic patients who were not on home oral anti-diabetic medications or who were not managed inpatient post-operatively, were excluded. Patient demographics and laboratory tests collected pre- and post-operatively as well as 90-day emergency department (ED) visits and 90-day readmissions, were pulled from electronic records. Patients were grouped based on inpatient diabetes management: continuation of home medications versus new insulin coverage. Acute post-operative BG control, creatinine levels, metabolic abnormalities, LOS, and early post-operative complications were compared between groups. Multivariable regression analyses were performed to measure associations.
RESULTS: A total of 867 primary TKAs were assessed; 703 (81.1%) patients continued their home oral antidiabetic medications. Continuing home anti-diabetic medications demonstrated lower median maximum inpatient BG (180.0 mg/dL versus 250.0 mg/dL; P < 0.001) and median average inpatient BG (136.7 mg/dL versus 173.7 mg/dL; P < 0.001). Logistic regression analyses supported the presence of an association (OR [odds ratio] = 17.88 [8.66, 43.43]; P < 0.001). Proportions of acute kidney injury (AKI) (13.5 versus 26.7%; P < 0.001) were also lower. There was no difference in relative proportions of metabolic acidosis (4.4 versus 3.7%; P = 0.831), LOS (2.0 versus 2.0 days; P = 0.259), or early post-operative complications.
CONCLUSION: Continuing home oral anti-diabetic medications after primary TKA was associated with lower blood glucose levels without an associated worsening creatinine or increase in metabolic acidosis.
METHODS: Patients diagnosed who had diabetes who underwent primary TKA from 2013 to 2022 were evaluated retrospectively. Diabetic patients who were not on home oral anti-diabetic medications or who were not managed inpatient post-operatively, were excluded. Patient demographics and laboratory tests collected pre- and post-operatively as well as 90-day emergency department (ED) visits and 90-day readmissions, were pulled from electronic records. Patients were grouped based on inpatient diabetes management: continuation of home medications versus new insulin coverage. Acute post-operative BG control, creatinine levels, metabolic abnormalities, LOS, and early post-operative complications were compared between groups. Multivariable regression analyses were performed to measure associations.
RESULTS: A total of 867 primary TKAs were assessed; 703 (81.1%) patients continued their home oral antidiabetic medications. Continuing home anti-diabetic medications demonstrated lower median maximum inpatient BG (180.0 mg/dL versus 250.0 mg/dL; P < 0.001) and median average inpatient BG (136.7 mg/dL versus 173.7 mg/dL; P < 0.001). Logistic regression analyses supported the presence of an association (OR [odds ratio] = 17.88 [8.66, 43.43]; P < 0.001). Proportions of acute kidney injury (AKI) (13.5 versus 26.7%; P < 0.001) were also lower. There was no difference in relative proportions of metabolic acidosis (4.4 versus 3.7%; P = 0.831), LOS (2.0 versus 2.0 days; P = 0.259), or early post-operative complications.
CONCLUSION: Continuing home oral anti-diabetic medications after primary TKA was associated with lower blood glucose levels without an associated worsening creatinine or increase in metabolic acidosis.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app